儿童肾脏实体肿瘤治疗方式的研究进展
Progress towards Therapies for Solid Renal Tumors in Children
DOI: 10.12677/acm.2024.1461769, PDF,    科研立项经费支持
作者: 林 洁, 石秦林, 田小毛:重庆医科大学附属儿童医院泌尿外科,国家儿童健康与疾病临床医学研究中心,儿童发育疾病研究教育部重点实验室,结构性出生缺陷与器官修复重建重庆市重点实验室,重庆;刘 丰*:重庆医科大学附属儿童医院泌尿外科,国家儿童健康与疾病临床医学研究中心,儿童发育疾病研究教育部重点实验室,结构性出生缺陷与器官修复重建重庆市重点实验室,重庆;四川大学华西第二医院小儿泌尿外科,出生缺陷与相关妇儿疾病教育部重点实验室,四川 成都
关键词: 肾脏肿瘤手术综述化疗放疗Renal Tumor Surgery Reviews Chemotherapy Radiotherapy
摘要: 近年来,大多数儿童肾肿瘤的治疗通过传统治疗手段(手术及放化疗)可得到有效治疗,但某些临床分期高,组织分化差的肿瘤复发率仍较高,总体生存率依旧较低。随着新技术、新理念不断出现,靶向、介入、消融、免疫、生物治疗成为目前肿瘤治疗研究关注度较高的治疗方式,在儿童肿瘤中亦取得丰富的研究成果。现对儿童肾脏肿瘤的治疗方式研究进展做一回顾性总结,以期为临床治疗个体化、多元化,改善患儿复发率及生存率起到一定的参考价值。
Abstract: Most pediatric kidney tumors could be effectively treated by traditional treatment (surgery, chemotherapy and radiotherapy) in recent years. However, there were a couple of patients, with high clinical stage and unfavorable histology, who were observed with high recurrent ratio and low overall survival rate. At the same time, some new treatments (including targeted therapy, interventional therapy, ablation treatment, immunotherapy and biotherapy) have been widely concerned and obtained a lot of research findings, with the development of new technology and conception. Therefore, in order to promote individual as well as diversity therapy and improve the recurrence and survival ratio, we summarized the research development of treatment in children’s kidney neoplasms.
文章引用:林洁, 石秦林, 田小毛, 刘丰. 儿童肾脏实体肿瘤治疗方式的研究进展[J]. 临床医学进展, 2024, 14(6): 245-254. https://doi.org/10.12677/acm.2024.1461769

参考文献

[1] Johnston, W.T., Erdmann, F., Newton, R., et al. (2021) Childhood Cancer: Estimating Regional and Global Incidence. Cancer Epidemiology, 71, Article 101662. [Google Scholar] [CrossRef] [PubMed]
[2] Zhao, Y., Sun, P., Xiao, J., et al. (2022) International Patterns and Trends of Childhood and Adolescent Cancer, 1978-2012. Journal of the National Cancer Center, 2, 78-89. [Google Scholar] [CrossRef] [PubMed]
[3] Tchuenkam, L.W., Nwaha Makon, A.S., Ongotsoyi, A.H.P., et al. (2023) Solid Malignant Retroperitoneal Masses in Children in a Low Resource Setting: Epidemiology, Clinicopathologic Characteristics, Treatment, Prognostic and Quality of Life after Surgery; a Cross-Sectional Analytic Study. Global Pediatrics, 3, Article 100028. [Google Scholar] [CrossRef
[4] Bhutani, N., Kajal, P. and Sharma, U. (2021) Many Faces of Wilms Tumor: Recent Advances and Future Directions. Annals of Medicine and Surgery, 64, Article 102202. [Google Scholar] [CrossRef] [PubMed]
[5] Li, H., Hohenstein, P. and Kuure, S. (2021) Embryonic Kidney Development, Stem Cells and the Origin of Wilms Tumor. Genes, 12, Article 318. [Google Scholar] [CrossRef] [PubMed]
[6] Stanescu, A.L., Acharya, P.T., Lee, E.Y., et al. (2019) Pediatric Renal Neoplasms: MR Imaging-Based Practical Diagnostic Approach. Magnetic Resonance Imaging Clinics of North America, 27, 279-290. [Google Scholar] [CrossRef] [PubMed]
[7] Cantoni, C., Serra, M., Parisi, E., et al. (2021) Stromal-Like Wilms Tumor Cells Induce Human Natural Killer Cell Degranulation and Display Immunomodulatory Properties towards NK Cells. Oncoimmunology, 10, Article 1879530. [Google Scholar] [CrossRef
[8] 刘峰, 赵强, 闫杰, 等. 儿童肾透明细胞肉瘤的临床分析[J]. 中国肿瘤临床, 2017, 44(24): 1258-1261.
[9] Furtwängler, R., Gooskens, S.L., van Tinteren, H., et al. (2013) Clear Cell Sarcomas of the Kidney Registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 Protocols: A Report of the SIOP Renal Tumour Study Group. European Journal of Cancer, 49, 3497-3506. [Google Scholar] [CrossRef] [PubMed]
[10] Farber, B.A., Shukla, N., Lim, I.I.P., et al. (2017) Prognostic Factors and Survival in Non-Central Nervous System Rhabdoid Tumors. Journal of Pediatric Surgery, 52, 373-376. [Google Scholar] [CrossRef] [PubMed]
[11] Enault, M., Minard-Colin, V., Corradini, N., et al. (2022) Extracranial Rhabdoid Tumours: Results of a SFCE Series of Patients Treated with a Dose Compression Strategy According to European Paediatric Soft Tissue Sarcoma Study Group Recommendations. European Journal of Cancer, 161, 64-78. [Google Scholar] [CrossRef] [PubMed]
[12] Slade, L. and Pulinilkunnil, T. (2017) The MiTF/TFE Family of Transcription Factors: Master Regulators of Organelle Signaling, Metabolism, and Stress Adaptation. Molecular Cancer Research, 15, 1637-1643. [Google Scholar] [CrossRef
[13] 钟海军, 王翔. 儿童肾细胞癌(RCC)的临床病理特征及手术疗效分析[J]. 复旦学报(医学版), 2020, 47(1): 24-30.
[14] Tomlinson, G.E., Breslow, N.E., Dome, J., et al. (2005) Rhabdoid Tumor of the Kidney in the National Wilms’ Tumor Study: Age at Diagnosis as a Prognostic Factor. Journal of Clinical Oncology, 23, 7641-7645. [Google Scholar] [CrossRef
[15] Gow, K.W., Barnhart, D.C., Hamilton, T.E., et al. (2013) Primary Nephrectomy and Intraoperative Tumor Spill: Report from the Children’s Oncology Group (COG) Renal Tumors Committee. Journal of Pediatric Surgery, 48, 34-38. [Google Scholar] [CrossRef] [PubMed]
[16] Spiegl, H.R., Murphy, A.J., Yanishevski, D., et al. (2020) Complications Following Nephron-Sparing Surgery for Wilms Tumor. Journal of Pediatric Surgery, 55, 126-129. [Google Scholar] [CrossRef] [PubMed]
[17] 胡忠, 陶俊. 开放性与腹腔镜肾脏部分切除术治疗肾脏肿瘤的疗效比较[J]. 浙江创伤外科, 2021, 26(5): 909-910.
[18] 蒋鸿飞, 林涛, 石秦林. 肾母细胞瘤综合治疗研究进展[J]. 临床小儿外科杂志, 2020, 19(10): 916-920.
[19] Mrad, C., Coulomb, L.A., Tabone, M.D., et al. (2020) Evaluation of the Nephron-Sparing Surgery Formula in Wilms Tumors. Pediatric Blood & Cancer, 67, e28661. [Google Scholar] [CrossRef] [PubMed]
[20] Lopyan, N.M. and Ehrlich, P.F. (2021) Surgical Management of Wilms Tumor (Nephroblastoma) and Renal Cell Carcinoma in Children and Young Adults. Surgical Oncology Clinics of North America, 30, 305-323. [Google Scholar] [CrossRef] [PubMed]
[21] Imam, N. and Burjonrappa, S. (2022) Nephron Sparing Surgery Outcomes in Wilms’ Tumor: Is It Ready for Primetime? Pediatric Surgery International, 39, Article No. 5. [Google Scholar] [CrossRef] [PubMed]
[22] Gao, H., Cheng, Q.Y., Zhao, Q., et al. (2021) Childhood Clear Cell Sarcoma of Kidney: Incidence and Survival. Frontiers in Pediatrics, 9, Article 675373. [Google Scholar] [CrossRef] [PubMed]
[23] El, K.M., Khattab, M., El, K.M., et al. (2004) Clear Cell Sarcoma of the Kidney. A Study of 13 Cases. Archives de Pédiatrie, 11, 794-799. [Google Scholar] [CrossRef] [PubMed]
[24] Koh, K.N., Han, J.W., Choi, H.S., et al. (2023) Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of the Korean Pediatric Hematology and Oncology Group (KPHOG) Data. Cancer Research and Treatment, 55, 279-290. [Google Scholar] [CrossRef] [PubMed]
[25] Fang, Y.W., Song, H.C., Sun, N., et al. (2022) Non-Wilms’ Renal Tumors in Children: Experience with 139 Cases Treated at a Single Center. BMC Urology, 22, Article No. 89. [Google Scholar] [CrossRef] [PubMed]
[26] Priyank, Y., Amita, M., Deepak, K.K., et al. (2018) Nephron-Sparing Surgery for Syndromic Wilms’ Tumor: Robotic Approach. Urology, 116, 172-175. [Google Scholar] [CrossRef] [PubMed]
[27] 吕雪雪, 李品, 陶元东, 等. 全球首例全机器人下单一体位儿童肾母细胞瘤根治术联合下腔静脉Ⅱ级瘤栓取出术[J]. 机器人外科学杂志(中英文), 2023, 4(2): 154-159.
[28] 杨小龙, 崔振宇, 马涛, 等. 三维可视化成像技术在机器人辅助肾部分切除术治疗复杂肾肿瘤中的应用[J]. 现代肿瘤医学, 2023, 31(7): 1311-1314.
[29] Vujanic, G.M., Gessler, M., Ooms, A., et al. (2018) The UMBRELLA SIOP-RTSG 2016 Wilms Tumour Pathology and Molecular Biology Protocol. Nature Reviews Urology, 15, 693-701. [Google Scholar] [CrossRef] [PubMed]
[30] Beckwith, J.B. (1986) Wilms Tumor and Other Renal Tumors of Childhood: An Update. The Journal of Urology, 136, 320-324. [Google Scholar] [CrossRef
[31] 中华医学小儿外科学分会泌尿外科学组. 儿童肾母细胞瘤诊疗专家共识[J]. 中华小儿外科杂志, 2020, 41(7): 585-589.
[32] 王金湖, 蔡嘉斌, 李民驹, 等. 儿童肾母细胞瘤国际及国内诊治方案解读[J]. 临床小儿外科杂志, 2020, 19(9): 765-774.
[33] Chintagumpala, M.M., Perlman, E.J., Tornwall, B., et al. (2022) Outcomes Based on Histopathologic Response to Preoperative Chemotherapy in Children with Bilateral Wilms Tumor: A Prospective Study (COG AREN0534). Cancer, 128, 2493-2503. [Google Scholar] [CrossRef] [PubMed]
[34] Gooskens, S.L., Graf, N., Furtwängler, R., et al. (2018) Position Paper: Rationale for the Treatment of Children with CCSK in the UMBRELLA SIOP-RTSG 2016 Protocol. Nature Reviews. Urology, 15, 309-319. [Google Scholar] [CrossRef] [PubMed]
[35] Pritchard-Jones, K., Bergeron, C., De Camargo, B., et al. (2015) Omission of Doxorubicin from the Treatment of Stage II-III, Intermediate-Risk Wilms’ Tumour (SIOP WT 2001): An Open-Label, Non-Inferiority, Randomised Controlled Trial. The Lancet, 386, 1156-1164. [Google Scholar] [CrossRef
[36] Wan, M.M., Chen, H., Da, W.Z., et al. (2021) Nitric Oxide-Driven Nanomotor for Deep Tissue Penetration and Multidrug Resistance Reversal in Cancer Therapy. Advanced Science, 8, Article 2002525. [Google Scholar] [CrossRef] [PubMed]
[37] Ortiz, M.V., Ahmed, S., Burns, M., et al. (2019) Prohibitin Is a Prognostic Marker and Therapeutic Target to Block Chemotherapy Resistance in Wilms’ Tumor. JCI Insight, 4, e127098. [Google Scholar] [CrossRef] [PubMed]
[38] Wang, J., Meng, D., Hu, Y., et al. (2023) Hyperthermic Intraperitoneal Chemotherapy for Recurrent Nephroblastoma in Children. Journal of the College of Physicians and Surgeons of Pakistan, 33, 170-175. [Google Scholar] [CrossRef] [PubMed]
[39] Laprie, A., Bernier, V., Padovani, L., et al. (2022) Guide for Paediatric Radiotherapy Procedures. Cancer/Radiothérapie, 26, 356-367. [Google Scholar] [CrossRef] [PubMed]
[40] Kalapurakal, J.A., Lee, B., Bautista, J., et al. (2019) Cardiac-Sparing Whole Lung Intensity Modulated Radiation Therapy in Children with Wilms Tumor: Final Report on Technique and Abdominal Field Matching to Maximize Normal Tissue Protection. Practical Radiation Oncology, 9, e62-e73. [Google Scholar] [CrossRef] [PubMed]
[41] Dávila, F.R., Pieters, B.R., Wilde, J.C.H., et al. (2020) A Role of Brachytherapy in Bilateral Wilms Tumors: A Long-Term Follow-Up of Three Highly Selected Cases and Literature Review. Brachytherapy, 20, 478-484. [Google Scholar] [CrossRef] [PubMed]
[42] Sardaro, A., Carbonara, R., Petruzzelli, M.F., et al. (2019) Proton Therapy in the Most Common Pediatric Non-Central Nervous System Malignancies: An Overview of Clinical and Dosimetric Outcomes. Italian Journal of Pediatrics, 45, Article No. 170. [Google Scholar] [CrossRef] [PubMed]
[43] Obasaju, P., Shahab, S., Dunn, E., et al. (2020) BRAF V600E-Mutated Metastatic Pediatric Wilms Tumor with Complete Response to Targeted RAF/MEK Inhibition. Cold Spring Harbor Molecular Case Studies, 6, a004820. [Google Scholar] [CrossRef] [PubMed]
[44] Kurmasheva, R.T., Kurmashev, D., Reynolds, C.P., et al. (2018) Initial Testing (Stage 1) of M6620 (Formerly VX-970), a Novel ATR Inhibitor, Alone and Combined with Cisplatin and Melphalan, by the Pediatric Preclinical Testing Program. Pediatric Blood & Cancer, 65, e26825. [Google Scholar] [CrossRef] [PubMed]
[45] 洪博, 董瑞. 肾母细胞瘤治疗研究进展[J]. 临床小儿外科杂志, 2021, 20(6): 569-575.
[46] Ge, N., Wang, H., He, C., et al. (2023) Optimal Interventional Treatment for Liver Cancer: HAIC, TACE or iTACE? Journal of Interventional Medicine, 6, 59-63. [Google Scholar] [CrossRef] [PubMed]
[47] Sieghart, W., Hucke, F. and Peck-Radosavljevic, M. (2015) Transarterial Chemoembolization: Modalities, Indication, and Patient Selection. Journal of Hepatology, 62, 1187-1195. [Google Scholar] [CrossRef] [PubMed]
[48] Wang, J.H., Li, M.J., Tang, D.X., et al. (2019) Neoadjuvant Transcatheter Arterial Chemoembolization and Systemic Chemotherapy for Treatment of Clear Cell Sarcoma of the Kidney in Children. Journal of Pediatric Surgery, 54, 550-556. [Google Scholar] [CrossRef] [PubMed]
[49] Li, M.J., Zhou, Y.B., Huang, Y., et al. (2011) A Retrospective Study of the Preoperative Treatment of Advanced Wilms Tumor in Children with Chemotherapy versus Transcatheter Arterial Chemoembolization Alone or Combined with Short-Term Systemic Chemotherapy. Journal of Vascular and Interventional Radiology, 22, 279-286. [Google Scholar] [CrossRef] [PubMed]
[50] Gomez, F.M., Patel, P.A., Stuart, S., et al. (2014) Systematic Review of Ablation Techniques for the Treatment of Malignant or Aggressive Benign Lesions in Children. Pediatric Radiology, 44, 1281-1289. [Google Scholar] [CrossRef] [PubMed]
[51] Laso-Garcia, I., Arias-Funez, F., Santiago-Gonzalez, M., et al. (2022) Prospective Long-Term Experience in the Treatment of Renal Tumors with Cryotherapy: Follow-Up with Computed Tomography Scan and Contrast-Enhanced Ultrasound. Central European Journal of Urology, 75, 265-271.
[52] Hont, A.B., Dumont, B., Sutton, K.S., et al. (2023) The Tumor Microenvironment and Immune Targeting Therapy in Pediatric Renal Tumors. Pediatric Blood & Cancer, 70, e30110. [Google Scholar] [CrossRef] [PubMed]
[53] Zhang, L., Jiao, H., Shen, M., et al. (2022) Clinical Significance of Tumoral PD-L1 Expression in Wilms Tumors. Journal of Pediatric Urology, 18, 11-14. [Google Scholar] [CrossRef] [PubMed]
[54] Picarda, E., Ohaegbulam, K.C. and Zang, X. (2016) Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy. Clinical Cancer Research, 22, 3425-3431. [Google Scholar] [CrossRef
[55] Dong, P., Xiong, Y., Yue, J., et al. (2018) B7H3 as a Promoter of Metastasis and Promising Therapeutic Target. Frontiers in Oncology, 8, Article 264. [Google Scholar] [CrossRef] [PubMed]
[56] Hont, A.B., Cruz, C.R., Ulrey, R., et al. (2019) Immunotherapy of Relapsed and Refractory Solid Tumors with ex vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I Study. Journal of Clinical Oncology, 37, 2349-2359. [Google Scholar] [CrossRef
[57] Brechbiel, M.W. (2018) A New Era of Cancer Biotherapy and Radiopharmaceuticals. Cancer Biotherapy and Radiopharmaceuticals, 33, 1-2. [Google Scholar] [CrossRef] [PubMed]
[58] Cesur-Ergun, B. and Demir-Dora, D. (2023) Gene Therapy in Cancer. The Journal of Gene Medicine, 25, e3550. [Google Scholar] [CrossRef] [PubMed]
[59] Liu, D., Zhao, X., Tang, A., et al. (2020) CRISPR Screen in Mechanism and Target Discovery for Cancer Immunotherapy. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1874, Article 188378. [Google Scholar] [CrossRef] [PubMed]
[60] Fallah, A., Heidari, H.R., Bradaran, B., et al. (2019) A Gene-Based Anti-Angiogenesis Therapy as a Novel Strategy for Cancer Treatment. Life Sciences, 239, Article 117018. [Google Scholar] [CrossRef] [PubMed]
[61] Muthukutty, P. and Yoo, S.Y. (2023) Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective. Viruses, 15, Article 1645. [Google Scholar] [CrossRef] [PubMed]
[62] Romao, R., van der Steeg, A., Malek, M., et al. (2023) Technical Advances in the Surgical Management of Wilms Tumors in Children. Pediatric Blood & Cancer, 70, e30267. [Google Scholar] [CrossRef] [PubMed]
[63] 张吉, 史学, 李海天, 等. 中西医结合治疗对恶性实体瘤患儿5年生存情况的影响[J]. 中国医药导报, 2019, 16(18): 117-120.
[64] Monteduro, A.G., Rizzato, S., Caragnano, G., et al. (2023) Organs-on-Chips Technologies—A Guide from Disease Models to Opportunities for Drug Development. Biosensors and Bioelectronics, 231, Article 115271. [Google Scholar] [CrossRef] [PubMed]
[65] Wegert, J., Zauter, L., Appenzeller, S., et al. (2020) High-Risk Blastemal Wilms Tumor Can Be Modeled by 3D Spheroid Cultures in Vitro. Oncogene, 39, 849-861. [Google Scholar] [CrossRef] [PubMed]
[66] Zhang, H., Li, Z., Gao, C., et al. (2021) Dual-Responsive Biohybrid Neutrobots for Active Target Delivery. Science Robotics, 6, eaaz9519. [Google Scholar] [CrossRef] [PubMed]
[67] Gu, H., Hanedan, E., Boehler, Q., et al. (2022) Artificial Microtubules for Rapid and Collective Transport of Magnetic Microcargoes. Nature Machine Intelligence, 4, 678-684. [Google Scholar] [CrossRef
[68] Walz, A.L., Fernandez, C.V. and Geller, J.I. (2019) Novel Therapy for Pediatric and Adolescent Kidney Cancer. Cancer and Metastasis Reviews, 38, 643-655. [Google Scholar] [CrossRef] [PubMed]